Metraipolis › archive › dc_d8cf7f73da65

GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and… — Europe PMC PMID:42280306

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42280306
DOI
10.3390/nu18111662
License (as archived)
solo-consultazione
Archived
2026-11-01T10:49:14.579Z
SHA-256 of the archived text
c16659da1ebff1143b326c4bbdf783c063c135fbe673a59ec94791fbfbc06a6c
Stable URL of this page
https://metraipolis.com/documento/dc_d8cf7f73da65

How to cite

GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and… — Europe PMC PMID:42280306 — Europe PMC (en), https://europepmc.org/article/MED/42280306 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8cf7f73da65 (Metraipolis archive dc_d8cf7f73da65, sha256 c16659da1ebff1143b326c4bbdf783c063c135fbe673a59ec94791fbfbc06a6c)
BibTeX
@misc{dcd8cf7f73da65,
  title = {GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and… — Europe PMC PMID:42280306},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42280306},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8cf7f73da65; sha256 c16659da1ebff1143b326c4bbdf783c063c135fbe673a59ec94791fbfbc06a6c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42280306. Agents can read the archived copy with the MCP tool read_document.